Literature DB >> 16777513

A quantitative evaluation of ST-segment changes on the 18-lead electrocardiogram during acute coronary occlusions.

Shu-Fen Wung1, David Y Kahn.   

Abstract

UNLABELLED: This study determined quantitative ST segment changes on the 18-lead electrocardiogram (ECG) during occlusions in each of the coronary arteries.
METHODS: Continuous 18-lead ECGs, including standard 12 leads, posterior (V7-9), and right ventricular (RV) leads (V3-5R) were recorded for 155 subjects undergoing percutaneous coronary occlusions, the maximum intervention.
RESULTS: During 58 left anterior descending (LAD) coronary occlusions, the maximum ST elevation and depression were in V3 (4.2 mm) and III (-0.9 mm), respectively. During 44 right coronary artery (RCA) occlusions, the maximum ST elevation and depression were in III (2.2 mm) and aVL (-1.4 mm), respectively. During 53 left circumflex (LCX) occlusions, the maximum ST elevation and depression were in V7 (0.8 mm) and V2 (-1.6 mm), respectively.
CONCLUSIONS: ST elevation often occurred in the anteroapical (V1-V6), lateral (I, aVL), and RV lead V(3R) during LAD occlusions; in the inferior, RV, and posterior leads during RCA occlusions; and in the posterior, inferior, and apical leads (V5-V6) during LCX occlusions.

Entities:  

Mesh:

Year:  2006        PMID: 16777513     DOI: 10.1016/j.jelectrocard.2005.10.007

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

1.  Unusual ECG pattern of the acute inferior wall infarction due to RCA occlusion with concomitant LAD and LCX disease.

Authors:  Iranna Hirapur; Rajeshwari Mantgol Veeranna; Navin Agrawal
Journal:  BMJ Case Rep       Date:  2014-04-23

Review 2.  Thoughts about the abnormalities in the electrocardiogram of patients with acute myocardial infarction with emphasis on a more accurate method of interpreting ST-segment displacement: part I.

Authors:  J Willis Hurst
Journal:  Clin Cardiol       Date:  2007-08       Impact factor: 2.882

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.